2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Boostrix: new trials by email Literature Review of Boostrix trials Research Report on Boostrix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd) Hepatitis A vaccine, Diphtheria, pertussis, and tetanus booster vaccine - Rheumatic Diseases | Phase 4 | Terminated | Oregon Health and Science University | 129 | 2022-10-11 | 2026-09-24 |
| Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines. INFANRIX, BOOSTRIX, HAVRIX - Acellular Pertussis, Tetanus | Phase 4 | Terminated | GlaxoSmithKline | 720 | 2003-05-01 | 2016-09-07 |
Diphtheria (1) · Rheumatic Diseases (1) · Tetanus (1)
GlaxoSmithKline (1) · Oregon Health and Science University (1)
Australia (1) · United States (1)